2.276 - 2.300 of 34.391
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 435,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 5,92x
- Analysis
- Novo Nordisk Call 425,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,57x
- Analysis
- Novo Nordisk Call 445,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,30x
- Analysis
- Novo Nordisk Call 495,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,03x
- Analysis
- Novo Nordisk Call 345,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,96x
- Analysis
- Novo Nordisk Call 335,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,35x
- Analysis
- Novo Nordisk Call 395,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,99x
- Analysis
- Novo Nordisk Call 405,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,08x
- Analysis
- Novo Nordisk Call 435,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,22x
- Analysis
- Novo Nordisk Call 285,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,60x
- Analysis
- Novo Nordisk Call 265,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,51x
- Analysis
- Novo Nordisk Call 405,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,37x
- Analysis
- Novo Nordisk Call 275,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,62x
- Analysis
- Novo Nordisk Call 535,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,23x
- Analysis
- Novo Nordisk Call 375,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,72x
- Analysis
- Novo Nordisk Call 485,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,88x
- Analysis
- Novo Nordisk Call 305,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,89x
- Analysis
- Novo Nordisk Call 315,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,14x
- Analysis
- Novo Nordisk Call 515,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,07x
- Analysis
- Novo Nordisk Call 295,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,77x
- Analysis
- Novo Nordisk Call 455,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,80x
- Analysis
- Novo Nordisk Call 315,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,29x
- Analysis
- Novo Nordisk Call 415,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,52x
- Analysis
- Novo Nordisk Call 525,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,17x
- Analysis
- Novo Nordisk Call 425,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,18x
- Analysis